To the editor Scleroderma is a disease characterized by functional and structural abnormalities in blood vessels and fibrous involvement of skin and internal organs. We studied hand dysfunction in 46 patients with scleroderma (four males and 42 females; mean age of 50.5 years; mean disease duration of 7.4 years). Twenty-nine presented the limited form, 11 presented the diffuse form and six cases overlapped with other connective tissue diseases. In this sample, 28.2% were employed workers; 10.8% were homemakers; 36.9%
Hand dysfunction in scleroderma patients
Disfunção da mão em pacientes com esclerodermia This questionnaire contains 11 questions about activities of daily living. It is measured through a Likert scale (0 = no difficulty; 1 = slight difficulty; 2 = moderate difficulty; 3 = impossible to perform) and ranges from 0 (no dysfunction) to 33 (maximum dysfunction). It was initially created to evaluate hand osteoarthritis but has also been used in scleroderma cases. 1 Patients with pain and stiffness were asked to grade their symptoms through a visual analogue scale (VAS) on which 0 corresponded to no symptoms and 10 to the maximum symptoms.
We found the following: RP in 93.5%; arthritis (present or previous) in 73.9%; hand stiffness in 73.9%; pain in the hand (overall) in 71.73%; arthralgia in 65.2%; skin ulcerations (present or previous) in 58.6%; and calcinosis in 26.6%. The Dreiser index results ranged from 0 to 25 (mean: 8.69 ± 8.02). The association between the Dreiser index and hand symptoms is shown in Table 1 .
The mean VAS obtained for pain in the hand was 7.12 ± 2.26 and for stiffness, it was 6.17 ± 2.05. There were positive correlations between the Dreiser index values and the VAS for pain (r = 0.47; P = 0.006) and between the index and the VAS for stiffness (r = 0.69;
Hand dysfunction is not always taken into account in scleroderma cases, but RobertsThomson et al. 5 showed that it can be as incapacitating as in rheumatoid arthritis.
We found that pain and stiffness were the symptoms that most affected functionality. Every effort should be directed towards treating these symptoms, in order to improve scleroderma patients' wellbeing. concluded that because of the higher prevalence of HBS, HCV and HIV positivity among blood donors who chose the confidential unit exclusion (CUE) option, offering CUE to blood donors could be a potentially useful method for improving blood safety, since it could increase the detection of infected blood during the window period.
I would like to open the issue for further discussion. Iran is an area of low endemicity for HCV infection, and the most common risk factors are histories of blood transfusion and intravenous addiction. 2, 3 However, for HBV infection, the most common risk factor is transmission during childhood, and most HBV-infected patients are unaware of their infection. 4 Donor selection is an important strategy for blood safety, but it is not enough! CUE, in which the physician asks the donor whether he or she wants his/her blood to be used for transfusion or not, has been added in order to obtain safer blood and blood products. The donor is asked to choose 
